People: Transcontinental Inc (TCLa.TO)

TCLa.TO on Toronto Stock Exchange

18 Sep 2019
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Marcoux, Isabelle 

Ms. Isabelle Marcoux serves as Non-Independent Chairman of the Board of Transcontinental Inc. Ms. Isabelle Marcoux is Chair of the Board of Transcontinental Inc. since February 16, 2012. Previously, she was Vice Chair of the Board since 2007 and Vice President, Corporate Development of Transcontinental Inc. since 2004. Between 1997 and 2004, she held the positions of Director, Mergers and Acquisitions and Director, Legal Affairs of the Corporation. Before joining Transcontinental, Ms. Marcoux was a lawyer at McCarthy Tétrault LLP, a law firm. In November 2015, Ms. Marcoux was appointed as a director of the Montreal Children’s Hospital. Furthermore, in 2016, Ms. Marcoux will co–chair the campaign of Centraide of Greater Montreal; In 2015, she was co-chair of the Leaders Circle Campaign for Centraide of Greater Montreal and participated in L’Effet A, an innovative program for women based on the premise that ambition changes the equation. Ms. Marcoux has co-chaired several fundraising campaigns, including the Fondation Tel-Jeunes, as well as many fundraising events, including for the Young Musicians of the World Foundation, the Montreal Children’s Hospital Gala in 2013, the Grand Bal des Vins- Coeurs for the Montreal Heart Institute Foundation in 2011 and the Montreal Museum of Fine Arts Ball in 2009. In 2015, Ms. Marcoux received the “Mercure Leadership Germaine-Gibara” award, Large Company category, for her exceptional contribution as a businesswoman. In 2014, she was named to the prestigious list of Canada’s Top 50 Business Leaders by Power & Influence magazine. In 2010 and 2012, Ms. Marcoux received the prestigious Canada’s Most Powerful Women: Top 100TM award. In 2010, Ms. Marcoux was named “Personality of the week” by La Presse and Radio–Canada and, in 2007, she was a recipient of Canada’s Top 40 under 40TM award.

Basic Compensation

Total Annual Compensation, CAD 688,644
Restricted Stock Award, CAD 150,007
Long-Term Incentive Plans, CAD --
All Other, CAD 149,380
Fiscal Year Total, CAD 988,031

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --